
Stryker Corporation SYK
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
382 M |
Market Cap[1] |
$ 116 B |
EBITDA (LTM) |
$ 6.46 B |
P/E (LTM) |
137.162896 |
P/S (LTM) |
16.156225 |
EPS (LTM) |
2.21 |
Stryker Corporation is an international company specializing in the production of medical equipment and instruments for surgery. The company was founded in 1941 in the United States and has since become one of the leaders in its field.
Stryker Corporation offers a wide range of products, including implants for orthopedics, neurosurgery, traumatology, and other areas of medicine, as well as tools for surgical operations and rehabilitation equipment.
The company is actively developing and expanding its business around the world. Today, SYK has offices in more than 100 countries and holds leading positions in the medical equipment market.
One of the company's main goals is to create innovative products that will help improve the quality of life for patients and facilitate the work of medical professionals. Stryker Corporation also actively works on improving its technologies and processes to ensure high-quality products and maximum safety for patients.
Stryker Corporation is an example of a successful business that combines innovation, quality, and responsibility to patients.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Vapotherm
VAPO
|
- | 6.72 % | $ 34 M | NYSE | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Titan Medical
TMDI
|
- | -26.32 % | $ 19.6 M | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
SeaSpine Holdings Corporation
SPNE
|
- | 0.28 % | $ 270 M | Nasdaq Global Select Market | ||
|
AxoGen
AXGN
|
$ 48.28 | 2.51 % | $ 2.22 B | Nasdaq Capital Market,SPB | ||
|
Bruker Corporation
BRKR
|
$ 58.5 | 0.13 % | $ 8.88 B | Nasdaq Global Select Market,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Establishment Labs Holdings
ESTA
|
$ 74.29 | 2.75 % | $ 2.2 B | Nasdaq Capital Market | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Abbott Laboratories
ABT
|
$ 108.33 | 0.19 % | $ 189 B | NYSE,SPB | ||
|
Aethlon Medical
AEMD
|
$ 1.82 | 6.04 % | $ 1.23 M | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 6.49 | 1.09 % | $ 877 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 158.64 | 0.03 % | $ 11.5 B | Nasdaq Global Select Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.05 | 0.32 % | $ 125 M | Nasdaq Global Select Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.27 | 0.3 % | $ 33.1 M | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 9.45 | 1.29 % | $ 1.42 B | Nasdaq Global Select Market | ||
|
Avanos Medical
AVNS
|
$ 24.99 | - | $ 1.16 B | NYSE,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Butterfly Network
BFLY
|
$ 7.36 | 0.96 % | $ 1.82 B | NYSE | ||
|
Bio-Rad Laboratories
BIO
|
$ 386.11 | 0.05 % | $ 10.5 B | NYSE,SPB | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 47.8 | 1.83 % | $ 70.8 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 8.47 | 0.71 % | $ 618 M | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 13.96 | 0.67 % | $ 395 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 49.32 | 0.02 % | $ 1.53 B | NYSE,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.35 | 0.03 % | $ 21.8 M | Nasdaq Capital Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 16.48 | 1.1 % | $ 590 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.